Despite lowering low-density lipoprotein (LDL), known as “bad” cholesterol, while markedly increasing levels of high-density lipoprotein (HDL), or “good” cholesterol, a large clinical trial to investigate the cholesterol drug evacetrapib was discontinued early after a preliminary analysis showed it did not reduce rates of major adverse cardiovascular events, according to new research.
from Top Health News – ScienceDaily http://bit.ly/1MMTGYf via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1VowNf6
No comments:
Post a Comment